Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: Association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma

Journal of Korean Medical Science

Volumn 16, Issue 4, 2001, Pages 424-432

  Choi, Yoon La ^a   Park, Seong Hoe ^b   Jang, Ja June ^b   Park, Cheol Keun ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Carcinoma, Hepatocellular; Dysplastic Nodule; Hepatitis B Virus; Protein cyclin D1; Protein p16; Protein p27; Protein p53

Indexed keywords

ACTIN BINDING PROTEIN; CYCLIN D1; CYCLINE; MUSCLE PROTEIN; PROTEIN P16INK4A; PROTEIN P53; RETINOBLASTOMA PROTEIN; TAGLN PROTEIN, MOUSE;

ADULT; AGED; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CHEMISTRY; FEMALE; HEPATITIS B; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PRECANCER; VIROLOGY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; G1 PHASE; HEPATITIS B; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETINOBLASTOMA PROTEIN; S PHASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035430322     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.4.424     Document Type: Article

References (43)

1. Schafer KA. The cell cycle: a review. Vet Pathol 1998; 35: 461-78.
2. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB. Amplification and expression of human cyclin D gene in esophageal cancer. Cancer Res 1992; 52: 2980-3.
3. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993; 90: 1112-6.
4. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994; 54: 380-5.
5. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-30.
6. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-7.
7. Michiell P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391-5.
8. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-92.
9. Shiohara M, eL-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994; 84: 3781-4.
10. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee YY, Bartram CY, Koeffler HP. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 1995; 55: 2266-9.
11. Kip1 gene in hepatocellular carcinoma. Cancer Lett 2000; 153: 169-73.
12. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
13. Hall PA, Levision DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP. Proliferating cell nuclear antigen immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 62: 285-94.
14. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Intern Med 1988; 108: 390-1.
15. Idilman R, De Maria N, Colantoni A, Van Thiel DH. Pathogenesis of hepatitis B and Cinduced hepatocellular carcinoma. J Viral Hepatitis 1998; 5: 285-99.
16. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Tanikuchi N, Monden M. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology 1999; 30: 90-9.
17. WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res 1998; 18: 555-64.
18. Peng SY, Chou SP, Hsu HC. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma. J Hepatol 1998; 29: 281-9.
19. Moon HY, Moon YM, Han KH, Chun JY, Kang JK, Park IS. Clinical aspect and prognosis according to the infection type of hepatitis virus in primary liver cancer. Korean J Med 1994; 47(Suppl): 33.
20. International working party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
21. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
22. Baker SJ, Preisinger AC, Jessup MJ, Paraskeva C, Markowitz S, Willson JKV, Hamilton S, Vogelstein B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50: 7717-22.
23. Kang YK, Kim CJ, Kim WH, Kim HO, Kang GH, Kim YI. p53 mutation and overexpression in hepatocellular carcinoma and dysplastic nodules in the liver. Virchows Arch 1998; 432: 27-32.
24. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 1954; 7: 462-503.
25. Hermanek P, Hutter RVP, Sobin LA, Wagner G, Wittekind CH. TNM atlas. 4th ed. UICC. Berlin: Springer, 1999; 115-23.
26. Liver Cancer Study Group of Japan. Classification of primary liver cancer. 1st ed. Tokyo: Kanehara press, 1997; 9-38.
27. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M, Ishizaki K. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994; 54: 3107-10.
28. Kip1 and apoptosis in human breast cancer. Br J Cancer 1999; 79: 1572-8.
29. Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma. Cancer 1999; 85: 1250-60.
30. Tenjo T, Toyoda M, Okuda J, Watanabe I, Yamamoto T, Tanaka K, Ohtani M, Nohara T, Kawasaki H, Tanigawa N. Prognostic significance of p27(KIP1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas. Oncology 2000; 58: 45-51.
31. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, DelSal G, Chau V, Yew PR, Draetta GF, Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269: 682-5.
32. Crary GS, Albrecht JH. Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology 1998; 28: 738-43.
33. WAF1/CIP1 gene expression in hepatic regeneration. Hepatology 1997; 25: 557-63.
34. Maki CG, Howley PM. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol 1997; 17: 355-63.
35. Shi YZ, Hui AM, Takayama T, Li X, Cui X, Makuuchi M. Reduced p21 (WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas. Br J Cancer 2000; 83: 50-5.
36. Kwon KW, Park YN, Park CI. p21 protein expression and cell proliferation activity in human multistep hepatocarcinogenesis. Korean J Pathol 2000; 34: 325-30.
37. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H. p16 (INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 1999; 116: 394-400.
38. INK4 in hepatocellular carcinoma. Hepatology 1996; 24: 575-9.
39. Zhang X, Xu H-J, Murakami Y, Sachse R, Yashima K, Hirohashi S, Hu S-X, Benedict WF, Sekiya T. Deletions of chromosome 13q, mutation in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 1994; 54: 4177-82.
40. Hui AM, Li X, Makuuchi M, Takayama T, Kubota K. Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int J Cancer 1999; 84: 604-8.
41. Seki S, Kawakita N, Yanai A, Kitada T, Sakai Y, Nakatani K, Yamada T, Sakaguchi H, Kuroki T. Expression of the retinoblastoma gene product in human hepatocellular carcinoma. Hum Pathol 1995; 26: 366-74.
42. Mise K, Tashiro S, Yogita S, Wada D, Harada M, Fukuda Y, Miyake H, Isikawa M, Izumi K, Sano N. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathological factors and prognosis. Clin Cancer Res 1998; 4: 1475-82.
43. Terada T, Nakanuma Y. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. Cancer 1992; 70: 591-8.